Articles From: Beiersdorf Profit Hit By Economic Downturn to BMO ETFs and Mutual Funds Recognized at Lipper Awards


2014/11/6
By Neetha Mahadevan FRANKFURT--German personal care company Beiersdorf AG (BEI.XE) on Thursday reported a drop in third-quarter net profit, dragged down by the economic downturn in many markets, particularly emerging economies.
Sign-up for Beiersdorf Profit Hit By Economic Downturn investment picks
2014/11/6
By Neetha Mahadevan FRANKFURT--German personal care company Beiersdorf AG (BEI.XE) on Thursday reported a drop in third quarter net profit, reflecting partly a write-down in its Chinese hair care business, and said conditions in some emerging markets will remain tough.
Sign-up for Beiersdorf Profit Hit by Economic Downturn -- 2nd Update investment picks
2014/11/6
By Neetha Mahadevan FRANKFURT--German personal care company Beiersdorf AG (BEI.XE) on Thursday reported a drop in third-quarter net profit, reflecting partly a write-down in its Chinese hair- care business, and said market conditions in emerging markets will remain tough.
Sign-up for Beiersdorf Profit Hit by Tough Market Environment -- Update investment picks
The Board of Directors of Bemis Company, Inc. (NYSE:BMS) has declared a regular quarterly dividend of 27 cents per share.
Sign-up for Bemis Company Declares Regular Quarterly Dividend investment picks
PHILADELPHIA, Nov.
Sign-up for Beneficial Bancorp, Inc. to Commence Second Step Conversion Stock Offering investment picks
Total revenue of $34.2 million grew 30% year-over-year CHARLESTON, S.C., Nov.
Sign-up for Benefitfocus Announces Third Quarter 2014 Financial Results investment picks
GFI Shareholders Urged to Tender Their Shares NEW YORK , Nov.
Sign-up for BGC's All-Cash Tender Clearly Represents Superior Value For GFI Shareholders investment picks
2014/11/6
Patented Healthcare Transparency Tool Offers More Affordable Prescription Drug Prices KANSAS CITY, Mo.
Sign-up for BH Media Group Selects RX Savings Solutions To Achieve Pharmaceutical Savings investment picks
2014/11/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977737001&sourceType=1 http://media3.marketwire.com/logos/20141003-BIGR.jpg http://www.ccnmatthews.com/logos/20050720-main_blank.gif CALGARY, ALBERTA --
Sign-up for Big Rock Brewery Inc. Announces Third Quarter Financial Results investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , today announced a joint research and development agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, to discover and develop novel nanomedicines for oncology.
Sign-up for BIND Therapeutics Announces Agreement with Merck to Develop Targeted Accurin™ Nanomedicines for Oncology investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today reported financial results and business highlights for the third quarter ended September 30, 2014.
Sign-up for BIND Therapeutics Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced the appointment of Amy P.
Sign-up for Bio-Path Holdings Appoints Amy P. Sing, M.D. to its Board of Directors investment picks
BioAmber Reports Third Quarter 2014 Financial Results Canada NewsWire MINNEAPOLIS, MN , Nov.
Sign-up for BioAmber Reports Third Quarter 2014 Financial Results investment picks
MINNEAPOLIS, MN , Nov.
Sign-up for BioAmber Reports Third Quarter 2014 Financial Results investment picks
RESEARCH TRIANGLE PARK, N.C., Nov.
Sign-up for BioCryst Reports Third Quarter 2014 Financial Results investment picks
Conference Call and Webcast at 4:30pm Eastern Time BOTHELL, Wash.
Sign-up for BioLife Solutions Announces Third Quarter 2014 Results investment picks
2014/11/6
Credit Suisse Biosimilars is a "must understand" theme that will have very significant impact on the global biotechnology and pharmaceutical sectors.
Sign-up for Biosimilars: The Good, the Bad and the Unknown -- Barron's investment picks
2014/11/6
Bird Construction Inc. announces improved 2014 third quarter financial results Canada NewsWire LISTING: TORONTO STOCK EXCHANGE SYMBOL: BDT TORONTO , Nov.
Sign-up for Bird Construction Inc. announces improved 2014 third quarter financial results investment picks
Black Box Corporation (NASDAQ:BBOX), a leading technology solutions provider, announced today that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of its Common Stock.
Sign-up for Black Box Corporation Declares Its Quarterly Cash Dividend investment picks
SALT LAKE CITY, Nov.
Sign-up for Black Diamond Equipment's 2014-15 Ski Collection Earns Over a Dozen Media Awards investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977593001&sourceType=1 http://media3.marketwire.com/docs/BlackBerry_logo_200.jpg WATERLOO, ONTARIO --
Sign-up for BlackBerry to Host Investor Day investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977694001&sourceType=1 http://www.ccnmatthews.com/logos/20090812-bplo.JPG CALGARY, ALBERTA --
Sign-up for BlackPearl Announces Third Quarter 2014 Financial and Operating Results investment picks
BlackRock Kelso Capital Corporation (NASDAQ:BKCC) (“BlackRock Kelso Capital” or the “Company”, “we”, “us” or “our”) announced today that its Board of Directors has declared a quarterly distribution of $0.21 per share payable on January 7, 2015 to stockholders of record as of December 24, 2014.
Sign-up for BlackRock Kelso Capital Corporation Declares Regular Quarterly Distribution of $0.21 per Share, Announces September 30, 2014 Quarterly Financial Results investment picks
bluebird bio, Inc. (Nasdaq: BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that data from its ongoing Phase 1/2 HGB-205 and Northstar Studies of LentiGlobin BB305 Drug Product will be presented at the 56th Annual Meeting of the American Society of Hematology (ASH) taking place December 6 – 9, 2014 in San Francisco, California.
Sign-up for bluebird bio to Present LentiGlobin Clinical Data at the American Society of Hematology Conference investment picks
- Adjusted EBITDA of $11.1 Million Best Since 2008 - - Excess Availability of $88 million - ATLANTA, Nov.
Sign-up for BlueLinx Announces Third-Quarter Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977357001&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg TORONTO, ONTARIO --
Sign-up for BMO Annual TFSA Report: Contributions Expected to Rise 34 Per Cent investment picks
2014/11/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977522001&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://www.ccnmatthews.com/logos/20110926-gamB.jpg TORONTO, ONTARIO --
Sign-up for BMO ETFs and Mutual Funds Recognized at Lipper Awards investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Beiersdorf Profit Hit By Economic Downturn to BMO ETFs and Mutual Funds Recognized at Lipper Awards
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent